3 days popular7 days popular1 month popular3 months popular

Sidley Austin To Reveal Guidance On UK Data Protection And Pharmacovigilance, 1-2 July 2013, London, UK

With just 4 weeks remaining until SMi open their doors to host the 3rd instalment in the conference series, SMi have announced that William Long, Partner at will be making a presentation on new policy.

The new presentation will provide:

  • Explanation of new UK Guidance on and PV
  • Understanding of background to EU data protection and PV
  • Development of the UK Guidance
  • Outline of the scope and main elements of the UK Guidance

The conference will aim to offer delegates with guidance on the main points to consider when presenting a PSUR to external regulatory bodies and tackle the issues and importance of adverse event reporting.

Attendees include:
EMA
Abbott
Federal Agency for Medicial and Health Products
Teva
Merck Serono
Roche
Gensyme
Johnson & Johnson
Novo Nordisk
Pharsafer
NDA Regulatory Science
Eli Lilly
MorphoSys
plus many more…

“…this Pharmacovigilance event brings experienced representative stakeholders together to generate a mutually-positive dialogue and cross-fertilized consensus on understanding, sharing, benchmarking and improving the way we operate within the discipline of Pharmacovigilance” – Abbott

To find out more visit http://www.pharmacovigilance-event.com.

Source

SMi Group Ltd